Clinical Trials Directory

Trials / Completed

CompletedNCT06832358

Positive Psychological Intervention for Parkinson's Disease Patients

Effect Evaluation of PERMA Positive Psychological Intervention Model in Parkinson's Disease Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
First Affiliated Hospital of Wenzhou Medical University · Academic / Other
Sex
All
Age
42 Years – 81 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the impact of positive psychological intervention based on the PERMA model on Parkinson's disease patients by assessing their depression, quality of life, and related psychological indicators before and after intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRoutine nursing methodsAccording to their condition, they receive individualized drug treatment, including the main drugs of Parkinson's disease (such as dopamine replacement drugs) and combined antidepressant drugs. Secondly, regular follow-up evaluations will be conducted to monitor disease progression and drug side effects. At the same time, patients and their families will receive health education on Parkinson's disease and depression.The patients would receive basic psychological support. Medical staff will encourage patients to express their emotions and pay attention to their psychological state, which will help alleviate anxiety and depression. Medical staff will provide patients with information about local support organizations and social groups, and encourage patients to participate in related activities to increase social interaction and emotional support.
BEHAVIORALPERMA positive psychological intervention mode(1) Formation of an intervention team.(2) Development and execution of interventions.The study group participated in a series of positive psychology workshop involving interviews and exercises aligned with the PERMA model as part of their routine health education. Each participant took part in individualized interviews focused on two specific topics each week until all subjects were covered, with each session lasting between 30 to 50 minutes. This interview phase continued for one month, conducted in the hospital ward.

Timeline

Start date
2022-02-01
Primary completion
2023-02-01
Completion
2023-04-01
First posted
2025-02-18
Last updated
2025-02-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06832358. Inclusion in this directory is not an endorsement.